BRAF and adenoma: Aggressive serrated BRAF-mutated/CIMP-positive/MSS tumors will probably necessitate more aggressive treatment and, potentially, different treatment agents than CRC exhibiting high levels of MSI or CRC resulting from the traditional adenoma–carcinoma sequence.